Sign in

CIK 0000093314

  • Non-accelerated filer
  • Smaller reporting company

VOLITIONRX LTD

Sign in to watch
Ticker
VNRX
Exchange
NYSE
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
911949078
Phone
+1 512-774-8930
Business address
1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON, NV, 89014
Former names
VOLITIONRX LTD, STANDARD CAPITAL CORP
Open-market buys, last 90 days
$6,848
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$6,848. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reynolds Cameron John +$7K President and CEO 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-01-22 Colman Alan Director Grant or award +12,000 257,364
2025-03-01 Colman Alan Director Grant or award +14,840 245,364
2025-01-29 Colman Alan Director Returned to the company · Stock Option (Right to Buy) −25,000 0
2025-01-29 Colman Alan Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2024-12-01 Colman Alan Director Grant or award +12,972 230,524
2024-09-01 Colman Alan Director Grant or award +13,757 217,552
2024-08-15 Colman Alan Director Grant or award +5,000 203,795
2024-06-01 Colman Alan Director Grant or award +12,016 198,795
2024-01-24 Colman Alan Director Grant or award +8,500 186,779
2023-07-05 Colman Alan Director Grant or award +6,750 178,279
2023-01-12 Colman Alan Director Grant or award +5,625 171,529

Page 1 of 1 · 11 trades